News
Are Indian startups heading for an extended funding winter this year? According to a recent CB Insights report, 2025 saw 653 ...
Ahead of its listing, Anthem Biosciences was commanding a strong grey market premium (GMP) of ₹179 in the unlisted market, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback